Bank of America
CLYM

Bank of America’s Climb Bio CLYM Stock Holding History

Bank of America’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Buy
52,921
+47,858
+945% +$276K ﹤0.01% 5061
2025
Q4 		$20.3K Sell
5,063
-690
-12% -$1.66K ﹤0.01% 6049
2025
Q3 		$11.6K Sell
5,753
-1,874
-25% -$3.48K ﹤0.01% 7174
2025
Q2 		$9.46K Sell
7,627
-29,660
-80% -$36.9K ﹤0.01% 7205
2025
Q1 		$45.5K Sell
37,287
-996,405
-96% -$1.62M ﹤0.01% 6776
2024
Q4 		$1.86M Buy
1,033,692
+1,016,323
+5,851% +$3.68M ﹤0.01% 4507
2024
Q3 		$88.4K Buy
17,369
+8,122
+88% +$57.5K ﹤0.01% 6375
2024
Q2 		$65.7K Buy
+9,247
New +$61.5K ﹤0.01% 6428
2024
Q1 		– Sell
-3
Closed -$8 – 8259
2023
Q4 		$8 Sell
3
-1,387
-100% -$3.61K ﹤0.01% 7816
2023
Q3 		$3.66K Buy
1,390
+471
+51% +$1.28K ﹤0.01% 7059
2023
Q2 		$2.57K Buy
919
+224
+32% +$680 ﹤0.01% 7107
2023
Q1 		$2.02K Sell
695
-4
-0.6% -$14 ﹤0.01% 7216
2022
Q4 		$2.56K Buy
699
+3
+0.4% +$9 ﹤0.01% 7185
2022
Q3 		$2K Sell
696
-2,688
-79% -$8.58K ﹤0.01% 7596
2022
Q2 		$10K Buy
3,384
+1,845
+120% +$8.73K ﹤0.01% 7400
2022
Q1 		$13K Sell
1,539
-2,760
-64% -$25.7K ﹤0.01% 7668
2021
Q4 		$45K Buy
4,299
+3,685
+600% +$54.9K ﹤0.01% 7267
2021
Q3 		$11K Buy
+614
New +$12.7K ﹤0.01% 7557

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Bank of America's CLYM Position: Q1 2026 in Review

Bank of America increased its Climb Bio (CLYM) stake by 945% in Q1 2026, buying an estimated $276K and bringing the position to 52,921 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #5061.

Bank of America first reported a position in CLYM in Q3 2021 and has held it in 18 quarters since. The position peaked at $1.86M in Q4 2024. 80 funds tracked by Wall St. Rank hold CLYM as of Q1 2026.

  • Bank of America held 52,921 shares of Climb Bio worth $363K as of Q1 2026.
  • Bank of America bought 47,858 Climb Bio shares in Q1 2026, an estimated $276K.
  • Climb Bio made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5061 holding.
  • Bank of America first reported a position in Climb Bio in Q3 2021 and has held it in 18 quarters since.
  • Bank of America's Climb Bio position peaked at $1.86M in Q4 2024.
  • 80 funds tracked by Wall St. Rank held Climb Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.